BWM
GILD icon

Brophy Wealth Management’s Gilead Sciences GILD Stock Holding History

Brophy Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.27M Buy
+15,203
New +$1.16M 0.46% 47

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Brophy Wealth Management's GILD Position: Q3 2024 in Review

Brophy Wealth Management opened a new position in Gilead Sciences (GILD) in Q3 2024: 15,203 shares worth $1.27M. The stake represents 0.46% of the portfolio and ranks #47 among its holdings.

1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Brophy Wealth Management held 15,203 shares of Gilead Sciences worth $1.27M as of Q3 2024.
  • Gilead Sciences was a new Brophy Wealth Management position in Q3 2024.
  • Gilead Sciences made up 0.46% of Brophy Wealth Management's portfolio in Q3 2024, its #47 holding.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Brophy Wealth Management's 13F filing for Q3 2024, filed 15 Nov 2024.